Studies on the pharmacokinetics and bioequivalence of domestic rosiglizole tablet in healthy volunteers

Chinese Pharmaceutical Journal

Volumn 38, Issue 7, 2003, Pages 523-525

  Zhou, Yan Wen ^a   Jiang, Wei Zhe ^a   Kong, Xiao Long ^a   Zhang, Xin Zhong ^b  

^a First Affil Hosp Guangxi Med U   (China)

^b Liuzhou Huaxi Grp Worker's Hospital   (China)

Author keywords

Bioavailability; HPLC; Rosiglizole

Indexed keywords

DRUG DOSAGE; DRUG PRODUCTS; FLUORESCENCE; STATISTICAL METHODS;

BIOAVAILABILITY;

BIOMEDICAL ENGINEERING;

ROSIGLITAZONE;

ARTICLE; BIOEQUIVALENCE; DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; TABLET;

EID: 0041429428     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Muxlow AM, Fowles S, Rusell P. Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasma[J]. J Chromatogr B, 2001, 752(1): 77.
2. Thompson K, Zussman B, Miller A, et al. Pharmacokinetics of rosiglitazone are unaltered in hemodialysis patients[J]. Clin Pharmacol Ther. 1999, 65(2): 186.